How Merck Keeps Prices for Its Blockbuster Cancer Drug Sky High

Ken Alltucker, Austin Fast and Sydney P. Freedberg, USA TODAY and ICIJ on April 14, 2026

One patient’s single infusion bill topped $162,000 — and a new investigation exposes the web of patents, Medicare lobbying, and dosing decisions that keep Keytruda out of generic competition.